392 research outputs found
Surgical innovation revisited: A historical narrative of the minimally invasive "Agarwal sliding-clip renorrhaphy" technique for partial nephrectomy and its application to an Australian cohort.
Objective
To evaluate local clinical outcomes of sliding clip renorrhaphy, from inception to current utilization for open, laparoscopic, and robotically assisted partial nephrectomy.
Methods
We reviewed prospectively maintained databases of three surgeons performing partial nephrectomies with the sliding-clip technique at teaching hospitals between 2005 and 2019. Baseline characteristics, operative parameters, including surgical approach, RENAL Nephrometry Score, and post-operative outcomes, including Clavien-Dindo classification of complications, were recorded for 76 consecutive cases. We compared perioperative and 90-day events with patient and tumor characteristics, stratified by operative approach and case complexity, using Wilcoxon rank-sum test for continuous variables and the Chi-squared or Fisher's exact test, for binary and categorical variables, respectively.
Results
Open surgery (nĀ =Ā 15) reduced ischemia time and operative time, but increased hospital admission time. Pre- and post-operative estimated glomerular filtration rates did not change significantly by operative approach. Older patients (PĀ =Ā .007) and open surgery (PĀ =Ā .003) were associated with a higher rate of complications (any-grade). Six grade ā„3 complications occurred: these were associated with higher RENAL Nephrometry Score (PĀ =Ā .016) and higher pathological tumor stage (PĀ =Ā .045). Limits include smaller case volumes which incorporate the learning curve cases; therefore, these data are most applicable to lower volume teaching hospitals.
Conclusion
The sliding-clip technique for partial nephrectomy was first described by Agarwal et al and has low complication rates, acceptable operative time, and preserves renal function across open and minimally invasive surgeries. This series encompasses the initial learning curve with developing the technique through to present-day emergence as a routine standard of practice
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
This is the final version. Available on open access from BMC via the DOI in this recordAvailability of data and materials:
The datasets generated and/or analysed during the current study are not publicly available as consent was not sought from participants to make data publically available. Data may be available from the corresponding author on reasonable request.Background
Active surveillance (AS) is a management option for men diagnosed with lower risk prostate cancer.
There is wide variation in all aspects of AS internationally, from patient selection to investigations
and follow-up intervals, and a lack of clear evidence on the optimal approach to AS. This study aimed
to provide guidance for clinicians from an international panel of prostate cancer experts.
Methods
A modified Delphi approach was undertaken, utilising two rounds of online questionnaires followed
by a face-to-face workshop. Participants indicated their level of agreement with statements relating
to patient selection for AS via online questionnaires on a 7-point Likert scale. Factors not achieving
agreement were iteratively developed between the two rounds of questionnaires. Draft statements
were presented at the face-to-face workshop for discussion and consensus building.
Results
12 prostate cancer experts (9 Urologists, 2 academics, 1 radiation oncologist) participated in this
study from a range of geographical regions (4 USA, 4 Europe, 4 Australia). Complete agreement on
statements presented to the participants was 29.4% after Round One and 69.0% after Round Two.
Following robust discussions at the face-to-face workshop, agreement was reached on the remaining
statements. PSA, PSA density, Multiparametric MRI, and systematic biopsy (with or without targeted
biopsy) were identified as minimum diagnostic tests required upon which to select patients to
recommend AS as a treatment option for prostate cancer. Patient factors and clinical parameters
that identified patients appropriate to potentially receive AS were agreed. Genetic and genomic
testing was not recommended for use in clinical decision-making regarding AS.
Conclusions
The lack of consistency in the practice of AS for men with lower risk prostate cancer between and
within countries was reflected in this modified Delphi study. There are, however, areas of common
practice and agreement from which clinicians practicing in the current environment can use to
inform their clinical practice to achieve the best outcomes for patients
Systematic Techniques to Enhance rEtention in Randomised controlled trials: the STEER study protocol
Background
Non-retention of participants seriously affects the credibility of clinical trial results and significantly reduces the potential of a trial to influence clinical practice. Non-retention can be defined as instances where participants leave the study prematurely. Examples include withdrawal of consent and loss to follow-up and thus outcome data cannot be obtained. The majority of existing interventions targeting retention fail to describe any theoretical basis for the observed improvement, or lack of improvement. Moreover, most of these interventions lack involvement of participants in their conception and/or design, raising questions about their relevance and acceptability. Many of the causes of non-retention involve people performing a behaviour (e.g. not returning a questionnaire). Behaviour change is difficult, and the importance of a strong theoretical basis for interventions that aim to change behaviour is increasingly recognised. This research aims to develop and pilot theoretically informed, participant-centred, evidence-based behaviour change interventions to improve retention in trials.
Methods
This research will generate data through semi-structured interviews on stakeholdersā perspectives of the reasons for trial non-retention. It will identify perceived barriers and enablers to trial retention using the Theoretical Domains Framework. The intervention development work will involve identification of behaviour change techniques, using recognised methodology, and co-production of retention interventions through discussion groups with end-users. An evaluation of intervention acceptability and feasibility will be conducted in focus groups. Finally, a ready-to-use evaluation framework to deploy in Studies Within A Trial as well as an explanatory retention framework will be developed for identifying and tackling modifiable issues to improve trial retention.
Discussion
We believe this to be one of the first studies to apply a theoretical lens to the development of interventions to improve trial retention that have been informed by, and are embedded within, participantsā experiential accounts. By developing and identifying priority interventions this study will support efforts to reduce research waste
Massless Spectra of Three Generation U(N) Heterotic String Vacua
We provide the methods to compute the complete massless spectra of a class of
recently introduced supersymmetric E8 x E8 heterotic string models which invoke
vector bundles with U(N) structure group on simply connected Calabi-Yau
manifolds and which yield flipped SU(5) and MSSM string vacua of potential
phenomenological interest. We apply Leray spectral sequences in order to derive
the localisation of the cohomology groups H^i(X,V_a \times V_b),
H^i(X,\bigwedge^2 V) and H^i(X,{\bf S}^2 V) for vector bundles defined via
Fourier-Mukai transforms on elliptically fibered Calabi-Yau manifolds. By the
method of bundle extensions we define a stable U(4) vector bundle leading to
the first flipped SU(5) model with just three generations, i.e. without any
vector-like matter. Along the way, we propose the notion of Lambda-stability
for heterotic bundles.Comment: 48 page
Searching for the Standard Model in the String Landscape : SUSY GUTs
The goal of the present review article is to describe the ingredients
necessary to find the Standard Model in the string landscape.Comment: 70 pages, 20 figures, this review article will be published in
Reports on Progress in Physic
Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
Background: Previous studies carried out in our laboratories have demonstrated impaired drug permeation in diabetic animals. In this study the permeation of diazepam (after a single dose of 5 mg/day, administered intramuscularly) will be investigated in diabetic and hypertensive pregnant women.Methods: A total 75 pregnant women were divided into three groups: group 1 (healthy control, n = 31), group 2 (diabetic, n = 14) and group 3 (hypertensive, n = 30). Two sets of diazepam plasma concentrations were collected and measured (after the administration of the same dose of diazepam), before, during and after delivery. The first set of blood samples was taken from the mother (maternal venous plasma). The second set of samples was taken from the fetus (fetal umbilical venous and arterial plasma). In order to assess the effect of diabetes and hypertension on diazepam placental-permeation, the ratios of fetal to maternal blood concentrations were determined. Differences were considered statistically significant if p=0.05.Results: The diabetes and hypertension groups have 2-fold increase in the fetal umbilical-venous concentrations, compared to the maternal venous concentrations. Feto: maternal plasma-concentrations ratios were higher in diabetes (2.01 Ā± 1.10) and hypertension (2.26 Ā± 1.23) groups compared with control (1.30 Ā± 0.48) while, there was no difference in ratios between the diabetes and hypertension groups. Umbilical-cord arterial: venous ratios (within each group) were similar among all groups (control: 0.97 Ā± 0.32; hypertension: 1.08 Ā± 0.60 and diabetes: 1.02 Ā± 0.77).Conclusions: On line with our previous findings which demonstrate disturbed transcellular trafficking of lipophilic drugs in diabetes, this study shows significant increase in diazepam placental-permeation in diabetic and hypertensive pregnant women suggesting poor transcellular control of drug permeation and flux, and bigger exposure of the fetus to drug-placental transport
- ā¦